TRPV2 and neoplasm: Indeed, we found the expression level of β-catenin was significantly down-regulated in immunocompetent xenograft models by TRPV2-PCNH-guided phototherapy (Supplementary Fig. 19), suggesting this treatment may transition the tumour microenvironment to a less resistant milieu.